4.95% 0.1199

Aclarion Inc (ACON)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Aclarion Inc Stock (ACON) Company Profile

Aclarion Inc

Healthcare (1069)

833 275 2266

8181 ARISTA PLACE, BROOMFIELD

최신 SEC 제출 서류

ACON's Discussions on Twitter

Compare ACON vs VEEV, BTSG, TEM, TXG, HQY

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ACON Aclarion Inc	2.54	6.98M	77,900	-8.05M	-7.47M	-9.2296
VEEV Veeva Systems Inc	260.98	42.25B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	57.88	11.45B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	58.74	10.66B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	66.38	8.65B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	94.55	7.82B	1.34B	230.70M	440.96M	2.6695

Aclarion Inc 주식(ACON)의 최신 뉴스

Aclarion Inc (ACON) 재무 분석

Aclarion Inc (ACON)

Aclarion Inc Stock (ACON) Company Profile

Compare ACON vs VEEV, BTSG, TEM, TXG, HQY

Aclarion Inc 주식(ACON)의 최신 뉴스

ACON Q2 2026 Earnings: Wider -$1.12 Per-Share Loss Sends Shares Down 4.76%Negative Surprise Momentum - vinanet.vn

Aclarion Inc (ACONW) Key Financial Ratios – Valuation, Profitability & More - Value Research

Aclarion (ACONW) Stock: Holds Near $0.03 in the Latest Reading; Chart View - vinanet.vn

Aclarion (ACON) Outlook: Moves 0.74% Higher to $2.71 on the Day; Price Setup: Traders Can Monitor the $2.57-$2.85 Range in Latest TradingIndex Put Call - vinanet.vn

Aclarion (ACON) Upgraded to Buy: Here's Why - Eastern Progress

Aclarion, Inc. Revenue Breakdown – NASDAQ:ACON - TradingView

Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Orthopedics This Week

AclarionAnticipates Having Initial Interna - Moomoo

Aclarion adds University of Arizona to Nociscan spine trial By Investing.com - Investing.com Australia

Aclarion adds University of Arizona to Nociscan spine trial - Investing.com

Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times

Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan

Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - vinanet.vn

Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria

Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com

Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks

Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria

Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - vinanet.vn

ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - quiverquant.com

Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com

Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks

Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Nigeria

Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria

Aclarion director Ryan Bond buys $50,059 in ACON shares By Investing.com - Investing.com Nigeria

Aclarion director David K. Neal buys $18,000 in common stock - Investing.com

Aclarion director William Wesemann buys $5,031 in company stock - Investing.com

Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com

Aclarion (ACON) director lifts stake to 23,713 shares - Stock Titan

Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et

Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times

Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative

Aclarion receives patent allowance for MRI scan technology - Investing.com

Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportCall Dominated - dars.gov.et

Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView

Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView

Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView

Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan

Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget

Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et

Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et

Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative

Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com

Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et

Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et

Aclarion Inc. Warrant (ACONW) Holds Steady at $0.02 as Trading Range CompressesNew Listing Stocks - dars.gov.et

ACON Q1 2026 Earnings: Narrower-than-Expected Loss Beats by 15.24%, Shares Advance 11.39%Full Year Guidance - vinanet.vn

Aclarion Inc. Warrant (ACONW) Flat at $0.02 as Support and Resistance ConvergeBuy Signal Reports - dars.gov.et

Aclarion Inc (ACON) 재무 분석

매출

순이익

현금흐름

주당 순 이익

ACON과 유사한 종목